Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Body size throughout the life-course and incident benign prostatic hyperplasia-related outcomes and nocturia.

BMC urologyยท2021
Same author

Baseline Basal Cell Hyperplasia Is not Associated With Baseline Lower Urinary Tract Symptoms, Baseline Clinical Prostatitis or Prostate Cancer in Repeat Biopsies.

Urologyยท2019
Same author

The association of atrophy in baseline prostate biopsy and lower prostate cancer grade in radical prostatectomy specimens.

Scandinavian journal of urologyยท2019
Same author

The combination of histological prostate atrophy and inflammation is associated with lower risk of prostate cancer in biopsy specimens.

Prostate cancer and prostatic diseasesยท2017
Same author

Does prostate volume correlate with vitamin D deficiency among men undergoing prostate biopsy?

Prostate cancer and prostatic diseasesยท2016
Same author

Baseline subject characteristics predictive of compliance with study-mandated prostate biopsy in men at risk of prostate cancer: results from REDUCE.

Prostate cancer and prostatic diseasesยท2016

Related Experiment Video

Updated: Jul 9, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Prostate carcinoma

G L Andriole1, W J Catalona

  • 1Division of Urologic Surgery, Washington University School of Medicine, St. Louis, Missouri 63110.

Annual Review of Medicine
|January 1, 1994
PubMed
Summary

Prostate-specific antigen (PSA) testing enables early prostate cancer detection. Anatomical radical prostatectomy offers effective tumor eradication with minimal side effects, confirmed by post-therapy PSA monitoring.

Area of Science:

  • Urology
  • Oncology
  • Medical Diagnostics

Background:

  • Prostate cancer management has advanced significantly.
  • Prostate-specific antigen (PSA) testing has improved early diagnosis.
  • Anatomical radical prostatectomy techniques have been refined.

Purpose of the Study:

  • To review the impact of PSA testing and radical prostatectomy on prostate cancer care.
  • To highlight the role of these advancements in early diagnosis and treatment.
  • To emphasize the effectiveness of surgery in eradicating early-stage tumors.

Main Methods:

  • Review of advancements in PSA testing.
  • Analysis of technical refinements in anatomical radical prostatectomy.
  • Evaluation of post-therapy PSA monitoring for treatment confirmation.

More Related Videos

Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia
08:38

Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia

Published on: August 28, 2013

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Related Experiment Videos

Last Updated: Jul 9, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia
08:38

Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia

Published on: August 28, 2013

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Main Results:

  • PSA testing facilitates early detection of organ-confined prostate cancer.
  • Anatomical radical prostatectomy demonstrates high efficacy in tumor eradication.
  • Minimal long-term morbidity is associated with the surgical procedure.
  • Post-therapy PSA levels confirm surgical success in eliminating cancer.

Conclusions:

  • PSA testing and refined prostatectomy have revolutionized prostate cancer care.
  • Early diagnosis and effective surgical treatment lead to improved patient outcomes.
  • Continued monitoring with PSA confirms the durable efficacy of surgical intervention.